Research News
View articles by month and year
-
Society Develops New Guidelines on Prophylactic Ovary Removal
New guidelines on protectively removing both ovaries and the fallopian tubes address the role this surgery can play in reducing the risk of both ovarian and breast cancer.
-
After Link Between Hormone Replacement Therapy and Risk Released, Breast Cancer Cases in Canada Went Down
The number of invasive breast cancer diagnoses went down in Canadian women after the 2002 publication of Women's Health Initiative results, similar to the decrease in U.S. women.
-
Risk in Women with Abnormal BRCA1 Gene Linked to Other Abnormal Genes
Researchers found that five abnormal genes on chromosome 19 are linked to a higher risk of breast cancer, especially in women with an abnormal BRCA1 gene.
-
Prophylactic Surgery Reduces Risk for Women with Abnormal Breast Cancer Genes
Women with an abnormal breast cancer gene who had prophylactic surgery lowered their risk of both ovarian and breast cancer.
-
Drinking Alcohol Increases Risk of Hormone-Receptor-Positive Breast Cancer
Regularly drinking alcohol increases the risk of lobular -- but not ductal -- hormone-receptor-positive breast cancer.
-
Hormone Replacement Therapy: Type and Time Used Linked to Increase in Risk
New research confirms that hormone replacement therapy increases the risk of hormone-receptor-positive breast cancer.
-
Number of White Girls Going Through Puberty at Younger Age Doubles
The number of white girls going through puberty at a younger age has doubled since the late 1990s, possibly increasing their future risk of breast cancer.
-
Male Relative with Breast Cancer Increases Risk Perception
Having a male relative diagnosed with breast cancer makes family members more aware of their own increased breast cancer risk, but doesn't make them more likely to do anything about this risk.
-
FDA Issues Warning on Evamist Spray
The U.S. Food and Drug Administration is warning women who use Evamist that children and pets shouldn't touch the skin where the HRT is sprayed.
-
Experimental Genomic Test May Help Predict Risk of Hormone-Receptor-Positive Disease Recurrence
An experimental test may be able to help predict the risk of hormone-receptor-positive breast cancer, but it's not clear how useful the test is.
